Participant flow

Letrozole in Patients With Ovarian Tumors · Source last updated 2012-04-18

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

groups

1. description

   2.5 mg by mouth (PO) daily

   id

   FG000

   title

   Letrozole

periods

1. drop Withdraws

   1. reasons

      1. group Id

         FG000

         num Subjects

         4

      type

      Not Eligible

   milestones

   1. achievements

      1. group Id

         FG000

         num Subjects

         16

      type

      STARTED

   2. achievements

      1. group Id

         FG000

         num Subjects

         12

      type

      COMPLETED

   3. achievements

      1. group Id

         FG000

         num Subjects

         4

      type

      NOT COMPLETED

   title

   Overall Study

pre Assignment Details

Study terminated early due to slow patient accrual.

recruitment Details

Recruitment Period: 09/24/03 through 01/30/08. All participants recruited at UT MD Anderson Cancer Center.

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice